Leading Pharmaceutical Operational Excellence (Record no. 51019)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02654nam a22005655i 4500 |
001 - CONTROL NUMBER | |
control field | 978-3-642-35161-7 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20200420211747.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 131126s2013 gw | s |||| 0|eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
ISBN | 9783642351617 |
-- | 978-3-642-35161-7 |
082 04 - CLASSIFICATION NUMBER | |
Call Number | 658.5 |
245 10 - TITLE STATEMENT | |
Title | Leading Pharmaceutical Operational Excellence |
Sub Title | Outstanding Practices and Cases / |
300 ## - PHYSICAL DESCRIPTION | |
Number of Pages | IX, 541 p. 263 illus. |
505 0# - FORMATTED CONTENTS NOTE | |
Remark 2 | Part A - Introduction -- Part B - Leading Operational Excellence - Outstanding Practices -- Part C - Leading Operational Excellence - Outstanding Leadership -- Part D - Gaining the Future. |
520 ## - SUMMARY, ETC. | |
Summary, etc | Achieving operational excellence is a challenge for the pharmaceutical industry, with many companies setting successful examples time and again. This book presents such leading practices for managing operational excellence throughout the pharmaceutical industry. Based on the St.Gallen OPEX Model the authors describe the current status of OPEX and the future challenges that have to be dealt with. The ample theoretical background is complemented hand-in-hand by case studies contributed by authors from leading pharmaceutical companies. |
700 1# - AUTHOR 2 | |
Author 2 | Friedli, Thomas. |
700 1# - AUTHOR 2 | |
Author 2 | Basu, Prabir. |
700 1# - AUTHOR 2 | |
Author 2 | Bellm, Daniel. |
700 1# - AUTHOR 2 | |
Author 2 | Werani, J�urgen. |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | http://dx.doi.org/10.1007/978-3-642-35161-7 |
942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
Koha item type | eBooks |
264 #1 - | |
-- | Berlin, Heidelberg : |
-- | Springer Berlin Heidelberg : |
-- | Imprint: Springer, |
-- | 2013. |
336 ## - | |
-- | text |
-- | txt |
-- | rdacontent |
337 ## - | |
-- | computer |
-- | c |
-- | rdamedia |
338 ## - | |
-- | online resource |
-- | cr |
-- | rdacarrier |
347 ## - | |
-- | text file |
-- | |
-- | rda |
650 #0 - SUBJECT ADDED ENTRY--SUBJECT 1 | |
-- | Business. |
650 #0 - SUBJECT ADDED ENTRY--SUBJECT 1 | |
-- | Management. |
650 #0 - SUBJECT ADDED ENTRY--SUBJECT 1 | |
-- | Leadership. |
650 #0 - SUBJECT ADDED ENTRY--SUBJECT 1 | |
-- | Production management. |
650 #0 - SUBJECT ADDED ENTRY--SUBJECT 1 | |
-- | Operations research. |
650 #0 - SUBJECT ADDED ENTRY--SUBJECT 1 | |
-- | Decision making. |
650 #0 - SUBJECT ADDED ENTRY--SUBJECT 1 | |
-- | Pharmaceutical technology. |
650 14 - SUBJECT ADDED ENTRY--SUBJECT 1 | |
-- | Business and Management. |
650 24 - SUBJECT ADDED ENTRY--SUBJECT 1 | |
-- | Operations Management. |
650 24 - SUBJECT ADDED ENTRY--SUBJECT 1 | |
-- | Business Strategy/Leadership. |
650 24 - SUBJECT ADDED ENTRY--SUBJECT 1 | |
-- | Pharmaceutical Sciences/Technology. |
650 24 - SUBJECT ADDED ENTRY--SUBJECT 1 | |
-- | Operation Research/Decision Theory. |
650 24 - SUBJECT ADDED ENTRY--SUBJECT 1 | |
-- | Management. |
912 ## - | |
-- | ZDB-2-SBE |
No items available.